Why the Certificate of Analysis Matters
When a vial of synthetic peptide arrives in the laboratory, the Certificate of Analysis (COA) is the primary document that communicates what is actually inside that vial. Unlike small-molecule drugs manufactured under pharmaceutical-grade controls, research peptides are produced for in vitro and preclinical investigational use. The COA is therefore the researcher's principal tool for verifying identity, purity, and batch-specific properties before any experiment begins. Misreading—or ignoring—a COA can introduce confounding variables that invalidate downstream data, waste reagents, and delay publications.
This article walks through each major section of a standard peptide COA, explains what the values mean analytically, and highlights red flags worth querying before use.
Peptide Identification Fields
Sequence and Single-Letter Code
At the top of every reputable COA you will find the amino acid sequence written in both single-letter and three-letter codes. Confirm this matches your purchase order exactly, paying particular attention to:
- D-amino acid residues, typically denoted with a lowercase letter (e.g., d-Ala) or a prefix such as D-Ala, which alter protease stability and receptor binding geometry.
- Non-standard residues such as Aib (α-aminoisobutyric acid) or Nle (norleucine), which must be listed explicitly.
- N- and C-terminal modifications — acetylation (Ac-), amidation (-NH₂), PEGylation, or fluorescent tags should appear as part of the sequence descriptor.
Molecular Formula and Theoretical Molecular Weight
The COA should state the molecular formula and the calculated (theoretical) average or monoisotopic molecular weight. This figure is derived from the sequence alone and serves as the expected value against which mass spectrometry data are compared. A mismatch between the theoretical MW and your own calculation is an immediate prompt to contact the supplier.
Batch or Lot Number
Every COA is batch-specific. When publishing results or troubleshooting experiments, the lot number allows you to trace analytical data precisely. Keep COAs filed alongside lab notebooks for at least the duration of any associated project.
Purity Data: HPLC Analysis
Purity is the single most critical quantitative value on the COA. Research peptides are routinely characterised by reversed-phase high-performance liquid chromatography (RP-HPLC), almost always using a C18 stationary phase with an acetonitrile/water gradient containing 0.05–0.1% trifluoroacetic acid (TFA).
Reported Purity Percentage
Purity is expressed as an area-under-the-curve (AUC) percentage at UV absorbance, most commonly 214 nm (which detects the peptide bond) or 220 nm. A value of ≥95% is standard for most biochemical assays; binding studies and cell-based experiments frequently demand ≥98% to reduce interference from truncated sequences or deletion products.
It is important to understand what this figure does not cover. HPLC purity at 214 nm does not quantify:
- Water content (see Karl Fischer titration, below)
- Residual TFA counter-ion content
- Inorganic salts or trace metals
- Endotoxin levels
These additional impurities require orthogonal analytical methods and are not always included on a standard COA.
Chromatogram Retention Time
Some COAs include the HPLC chromatogram as an embedded image or appendix. If present, examine the trace for:
- A dominant, sharp principal peak with minimal shoulders or satellite peaks
- A baseline that returns cleanly to zero between peaks
- Absence of a large early-eluting peak, which can indicate hydrophilic impurities or residual reagents
Identity Confirmation: Mass Spectrometry
Electrospray ionisation mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionisation time-of-flight MS (MALDI-TOF) is used to confirm peptide identity. The COA will report:
- Observed m/z values for one or more charge states
- Calculated mass derived from the observed m/z and charge state z, using the formula: M = (m/z × z) − (z × 1.0073) for ESI
- Δ mass, the difference between observed and theoretical mass, which should be within ±0.5 Da for average mass or ±0.02 Da for high-resolution instruments
Multiple charge states in ESI-MS are normal and expected for peptides longer than approximately five residues. The deconvoluted mass should still agree with the theoretical value within the instrument's tolerance. A mass shift of +16 Da may indicate oxidation of methionine or tryptophan; +80 Da may suggest inadvertent phosphorylation or a sulfonation artefact — both warrant investigation.
Supporting Analytical Data
Water Content by Karl Fischer Titration
Lyophilised peptides absorb atmospheric moisture and can contain 5–15% water by weight. The Karl Fischer (KF) titration quantifies this. If a COA reports KF water content, you can calculate the net peptide content of your sample — relevant when precise molarity must be established for stoichiometric experiments.
Peptide Content by Amino Acid Analysis
High-quality suppliers may include amino acid analysis (AAA) data, which provides an absolute measure of peptide mass independent of UV extinction coefficients. This is particularly valuable for peptides lacking strong chromophores (i.e., no Trp, Tyr, or Phe residues) where spectrophotometric quantification is unreliable.
Appearance and Solubility
Most COAs include a brief description of physical appearance (e.g., white to off-white lyophilised powder) and may note recommended reconstitution solvents. This is not a trivial field: highly hydrophobic peptides that are described as soluble in DMSO but not aqueous buffer require specific handling to prevent aggregation that alters experimental outcomes.
Storage and Stability Conditions
COA storage recommendations are analytically grounded. Peptides containing cysteine, methionine, or tryptophan are susceptible to oxidation and are typically stored under inert gas at −80 °C. Disulfide-bridged peptides may be sensitive to reducing environments. The stated shelf life applies to the unopened, lyophilised vial under recommended conditions; once reconstituted, stability is substantially reduced and should be verified independently for each experimental system.
Red Flags and When to Contact the Supplier
A COA should prompt direct communication with the supplier if any of the following are present:
- Reported purity below the specification listed at purchase
- Observed mass differing from theoretical by more than the instrument tolerance
- Missing mass spectrometry data entirely
- Sequence described as "on request" rather than printed on the document
- No lot number or date of analysis
- Chromatogram showing multiple peaks of comparable area to the principal peak
Integrating COA Data into Laboratory Records
Best practice is to cross-reference the COA against the original purchase specification, record the lot number in the laboratory notebook on the day of first use, and archive the document in a format that links it to any resulting experimental data. If a peptide will be used across multiple experiments over months, periodic re-testing of reconstituted aliquots by in-house HPLC—where equipment permits—can detect degradation that post-dates the original analysis.
For research use only. The information in this article is intended to support qualified laboratory researchers working with synthetic peptides in preclinical and in vitro research settings. It does not constitute medical advice, therapeutic guidance, or dosing instruction of any kind.